Our Autonomic Nervous System (ANS) device is FDA Cleared and Measures Arterial Stiffness, Vascularization and Endothelial Function.

Identify Heart Attack and Stroke Risks Early

Diabetes/prediabetes and Cardiovascular disease (CVD) are two of the most prevalent chronic diseases that lead to death in the United States. In 2015, about 9% of the U.S. population had been diagnosed with diabetes while another 3% were undiagnosed. Furthermore, about 34% had prediabetes. However, of those adults with prediabetes almost 90% of them were unaware of their condition [1]. CVD on the other hand is the leading cause of one in four deaths every year in the U.S. [2]. Additionally, there is a correlation between CVD and diabetes. American Heart Association reports at least 68% of people age 65 or older with diabetes, die of heart disease [4]. A systematic literature review by Einarson et al. [5], the authors concluded that 32.2% of all patients with type 2 diabetes are affected by heart disease.

68% of People Age 65 or Older with Diabetes Die of Heart Disease

Diabetic Cardiomyopathy is a disorder of the heart muscle in people with diabetes. It can lead to the inability of the heart to circulate blood through the body effectively, a state known as heart failure, with accumulation of fluid in the lungs (pulmonary edema) or legs (peripheral edema). Patients with diabetes Type 2 have up to a 74% increased risk of developing Heart Failure, and diabetic patients with HF are four times more likely to die than those without Heart Failure. Importantly, unrecognized Heart Failure is highly prevalent in Type 2 diabetics, with over one quarter (27.7%) of over 60's having previously undiagnosed Heart Failure in one report. Therefore it is one, if not the most important assessment to be measured for all Type 2 diabetic patients. Our test measures and graphs the heartbeat as it moves through systolic and diastolic during a 3-minutes screening to attain an overall cardiovascular assessment. The medical device uses a sophisticated algorithm to track variations that are not visible to the naked eye and interprets those results against a vast body of research.

Medical providers need to be made aware of the potential impact of cardiovascular conditions and complications in COVID-19 patients who require more intensive and frequent cardiovascular monitoring.

COVID-19 infection may cause a number of clinically significant cardiovascular events in connection with what is being called Post COVID Syndrome or Long COVID. COVID-19 infection may cause a number of clinically significant cardiovascular events in connection with what is being called Post-COVID Syndrome or Long COVID. An indirect effect is related to the delayed diagnosis of urgent non-COVID conditions, because of concern with going to a hospital. This has led to upticks in out-of-hospital heart attacks and strokes.¹

https://www.practicalpainmanagement.com/resources/practice-management/covid-19-long-haulers-look-cardiovascular-risk